星球细胞作为代谢传感器,调节阿尔茨海默氏病中的能量驱动的大脑脆弱性
Leyre Sánchez de Muniain1,2, Paula Escalada1,2, María J Ramírez1,2
1Department of Pharmaceutical Sciences, University of Navarra, Pamplona, Spain.
Journal of neurochemistry
|October 7, 2025
概括
阿尔茨海默病 (AD) 涉及到矛盾的脑代谢. 星球细胞重新编程能量使用,可能导致神经炎症和加速AD,提供新的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 衰老研究研究 衰老研究
背景情况:
- 阿尔茨海默病 (AD) 是主要的与年龄相关的神经退行性疾病.
- 阿尔茨海默病呈现一种代谢悖论:细胞能量需求的增加与老龄化中的稳定或下降的能量消耗形成对比.
- 大脑在响应来自老化组织的全身高代谢信号时节省能量.
研究的目的:
- 在阿尔茨海默氏症早期阶段探索星球细胞代谢重编程.
- 为了研究星球细胞能量如何促进神经炎症,氧化应激和AD进展.
- 根据天体细胞代谢识别潜在的新生物标志物和阿尔茨海默病的治疗策略.
主要方法:
- 关于老化和阿尔茨海默氏病中的天体细胞代谢的当前文献的综述.
- 分析星体细胞作为能量传感器和大脑新陈代谢调节器的作用.
- 在AD早期阶段探索星球细胞中的代谢重编程.
主要成果:
- 星球细胞在感知全身压力和调节大脑能量代谢方面发挥着至关重要的作用.
- 在星球细胞中早期的代谢重编程可能会随着时间的推移变得不适应.
- 这种不适应的重编程可以促进神经炎症和氧化应激,加速AD的发病.
结论:
- 了解星球细胞能量对于理解AD发展至关重要.
- 准天体细胞代谢为新型AD生物标志物提供了有希望的途径.
- 调节天体细胞能量是一种潜在的治疗策略,可以改变AD治疗.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Neuron Structure
17.8K
Neurons are the main type of cell in the nervous system that generate and transmit electrochemical signals. They primarily communicate with each other using neurotransmitters at specific junctions called synapses. Neurons come in many shapes that often relate to their function, but most share three main structures: an axon and dendrites that extend out from a cell body.
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
Structure and Function of Neurons
The neuronal cell body—the soma— houses the nucleus and organelles vital to...
17.8K
Glial Cells
93.1K
Overview
93.1K
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822


